Ferrante Karen Jean — SEC insider filings
SEC reporting owner CIK 1598502. 38 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers all 38 filings on record, filed 2020-10-02 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 48.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | Director | 31 | — | — | 31 |
| MACROGENICS INC (MGNX) | Director | 7 | — | — | 17 |
Insider filings — Ferrante Karen Jean
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 759 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 627 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 17,901 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | MACROGENICS INC (MGNX) | Option exercise (M): 3,750 · Option exercise (M): 3,750 (derivative) @ $0 · Grant/award (A): 3,750 (derivative) @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 686 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 643 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 1,642 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 3,314 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | MACROGENICS INC (MGNX) | Option exercise (M): 6,500 · Option exercise (M): 6,500 (derivative) @ $0 · Grant/award (A): 3,750 (derivative) @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 3,788 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,785 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,034 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,462 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | MACROGENICS INC (MGNX) | Grant/award (A): 6,500 (derivative) @ $0 · Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | MACROGENICS INC (MGNX) | Option exercise (M): 4,500 @ $0 · Option exercise (M): 4,500 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 3,213 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 3,298 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,345 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 1,884 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 36,700 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | MACROGENICS INC (MGNX) | Grant/award (A): 19,000 (derivative) @ $0 · Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,053 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 1,862 (derivative) @ $7.19 | EDGAR |
| 2022-10-04 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 1,474 (derivative) @ $9.08 | EDGAR |
| 2022-07-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,279 (derivative) @ $5.87 | EDGAR |
| 2022-06-09 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | MACROGENICS INC (MGNX) | Grant/award (A): 18,000 (derivative) @ $0 · Grant/award (A): 20,640 (derivative) @ $0 | EDGAR |
| 2022-04-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,753 (derivative) @ $4.86 | EDGAR |
| 2022-01-04 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,329 (derivative) @ $5.15 | EDGAR |
| 2021-10-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,385 (derivative) @ $5.03 | EDGAR |
| 2021-07-06 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,513 (derivative) @ $4.78 | EDGAR |
| 2021-05-17 | 4 | MACROGENICS INC (MGNX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-04-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,121 (derivative) @ $5.66 | EDGAR |
| 2021-03-15 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 1,575 (derivative) @ $0 | EDGAR |
| 2020-10-02 | 4 | Unum Therapeutics Inc. (UMRX) | Grant/award (A): 8,878 (derivative) @ $1.35 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1598502 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs